Where is the live CopyMark page for USPTO serial 79097185?

The live record is at https://getcopymark.com/trademark/79097185. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns DEVRO MEDICAL DEVRO MEDICAL LIMITED?

According to the public USPTO record for serial number 79097185, the listed owner(s) include: DEVRO PLC.

What is USPTO serial number 79097185?

Serial number 79097185 is the USPTO application identifier for the mark DEVRO MEDICAL DEVRO MEDICAL LIMITED. It is used to track examination, publication, and registration of this trademark.

What is the current status of DEVRO MEDICAL DEVRO MEDICAL LIMITED?

DEVRO MEDICAL DEVRO MEDICAL LIMITED (79097185) currently shows USPTO status code 402 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover DEVRO MEDICAL DEVRO MEDICAL LIMITED?

The public record lists International Classes: 001, 003, 005, 010. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: DEVRO MEDICAL DEVRO MEDICAL LIMITED Serial# 79097185 | status 402; last event DENA | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DEVRO MEDICAL DEVRO MEDICAL LIMITED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

DEVRO PLC
GB
Other trademarks owned by DEVRO PLC

Goods and services

Class	Description	Status	First use
001	Biomedical collagen; coatings for biomedical devices; cell coatings; coatings for tissue engineering; tissue culture coatings; coatings for bioengineering scaffolding; collagen-based ingredients for cosmetic preparations; purified soluble collagen; acid solubilised collagen; pepsin solubilised collagen; fibrous or fibrillar active agents. (all aforementioned terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations)	SECTION 70 - CANCELLED	—
003	Collagen preparations for cosmetic application	SECTION 70 - CANCELLED	—
005	Pharmaceutical preparations; medical or pharmaceutical preparations containing or consisting of collagen; wound dressings or coatings therefor; surgical dressings incorporating or consisting of collagen; haemostats (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); collagen-based medicated supplements for food; biological reagents for use in molecular biology; chemical reagents for molecular biology for medical or veterinary use; collagen film for medical or veterinary use; gelatins for medical purposes; biological glues; biological anti-adhesives; pharmaceutical preparations, namely, collagen (proteins) as a method for delivery of other active agents	SECTION 70 - CANCELLED	—
010	Medical and surgical apparatus and instruments; hemostats and coatings therefor; sponges of collagen or coated therewith for wounds; collagen film for treating wounds; prosthetic implant coatings	SECTION 70 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Nov 21, 2020	DENA	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED	—
Nov 20, 2020	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Jun 2, 2016	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Aug 7, 2014	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Feb 7, 2013	FINT	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Jan 11, 2013	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Jan 11, 2013	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Nov 24, 2012	OPNX	NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB	—
Nov 7, 2012	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
Nov 7, 2012	OPNR	NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB	—
Jan 11, 2012	MAB2	ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND	The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 11, 2012	ABN2	ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 28, 2011	RFNT	REFUSAL PROCESSED BY IB	—
Jun 9, 2011	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Jun 7, 2011	MAFR	APPLICATION FILING RECEIPT MAILED	—
Jun 6, 2011	RFRR	REFUSAL PROCESSED BY MPU	—
Jun 6, 2011	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Jun 5, 2011	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2011	DOCK	ASSIGNED TO EXAMINER	—
Jun 3, 2011	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Jun 2, 2011	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

DEVRO MEDICAL DEVRO MEDICAL LIMITED